Equities

Control Bionics Ltd

CBL:ASX

Control Bionics Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.066
  • Today's Change0.00 / 0.00%
  • Shares traded612.00
  • 1 Year change+32.00%
  • Beta0.8091
Data delayed at least 20 minutes, as of Nov 15 2024 00:42 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

As of last trade, Control Bionics Ltd (CBL:ASX) traded at 0.066, 100.00% above the 52 week low of 0.033 set on Dec 12, 2023.
52-week range
Today
0.033Dec 12 20230.105Aug 21 2024
Open0.066
High0.066
Low0.066
Bid0.06
Offer0.064
Previous close0.066
Average volume96.97k
Shares outstanding247.56m
Free float185.16m
P/E (TTM)--
Market cap16.34m AUD
EPS (TTM)-0.0381
AUD
Data delayed at least 20 minutes, as of Nov 15 2024 00:42 GMT.
More ▼

Events & Activity

  • CBL:ASX price moved over +4.84% to 0.065
  • CBL:ASX price rises above 15-day moving average to 0.065 at 23:46 GMT
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.